The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, is pleased to announce a combination of brand-new and well-established events happening in March, tackling two specific areas of oncology, with leading experts discussing novel clinical data and the latest treatment options.
ESMO Sarcoma and Rare Cancers Congress 2023
The ESMO Sarcoma and Rare Cancers Congress 2023 is dedicated to presenting and discussing the developments in the treatment and care of rare adult solid cancers.
The event will take place in Lugano, Switzerland on 20-22 March 2023.
Programme highlights
- Novel clinical data to optimise clinical decisions in rare cancers
Sessions: Proffered paper rare cancers and Proffered paper sarcoma - New therapeutic approaches and recent developments in the molecular characterisation and epigenetics of sarcoma, an evolving landscape for better understanding the disease
Sessions: Evolving classification of sarcomas and The evolution of local/ablative therapeutic approaches in sarcomas - How to balance the increasing number of subtypes with limited knowledge on natural history, access to innovation and new methods for clinical investigation to progress research and improve patient outcomes in ultra rare sarcomas
Session: Ultra rare sarcomas - Understanding the unmet needs of cancer patients affected by rare pathologies to change the future of research, finding better treatments and improving prognosis in:
- Gynaecological and genitourinary cancers
Sessions: Challenges in diagnosis and treatment of rare gynaecological and genitourinary cancers and Improving the continuum of care in rare gynaecological and genitourinary oncology - Thoracic and head & neck tumours
Session: Managing patients with ultra rare thoracic and head neck tumours of ultra rare histologies - Digestive cancers and gastroenteropancreatic neuroendocrine neoplasms
Sessions: Rare digestive and Management of GEP NENs - Non-skin melanoma, adnexal tumours and Merkel cell carcinoma
Session: Non-skin melanoma, adnexal tumours and Merkel cell carcinoma - Central nervous system tumours
Session: State-of-the-art diagnosis and management of rare primary CNS tumours - Adrenal tumours
Session: Management of adrenal tumours
- Gynaecological and genitourinary cancers
- The importance of healthcare networking to boost innovative research and development
Session: Health care networking in the EU about cancer and rare cancers - The value of patient’s input and voice throughout the research process and how patient advocacy can become a key factor of advancement in rare cancers
Sessions: SPAGN session: Research for patient benefit and Patient advocacy on rare cancers
European Lung Cancer Congress 2023
The European Lung Cancer Congress (ELCC) 2023, is the annual event dedicated to advancing the science, disseminating education and improving the practice of lung cancer experts worldwide.
The event will take place in Copenhagen, Denmark from 29 March – 1 April 2023 and online through a dedicated virtual platform.
Programme highlights
- Innovative clinical data and drugs on the horizon to improve therapeutic approaches
Sessions: Proffered Paper session 1,Proffered Paper session 2 and New therapeutic classes: ADCs, biospecifics and novel IO agents - The clinical challenge with immunotherapy and targeted therapies:
- Patterns of emergence and management of resistance
Session: Resistance after IO and targeted therapies: Patterns of emergence and management - Peri-operative strategies
Session: Peri-operative strategies in early stage NSCLC with IO and targeted therapies and abstract 84O (Proffered paper 2)
- Patterns of emergence and management of resistance
- Applying liquid biopsy as part of an integrated genomic service to maximise outcomes from molecular diagnosis
Session: Updates on molecular diagnosis - New early detection and screening recommendations to reduce the disease burden
Sessions: Harnessing the power of screening in lung cancer and Screening and early detection - Supportive care strategies to ameliorate quality of life and optimise cancer outcomes
Session: Optimising cancer outcomes through supportive care - Fundamental insights in the impact of environmental and other risk factors beyond tobacco
Sessions: Lung cancer beyond tobacco: Impact of environmental and other risk factors and keynote lecture Air pollution and lung cancer
Keynote lectures
- “Heine H. Hansen 2023 Award Keynote Lecture (Title to be announced)” by Paul Baas, Heine H. Hansen 2023 Award recipient, 29 March 2023, 13:45-14:15 CEST
- “Equity and sustainability in lung cancer care in resource-restricted contexts” by Clarissa Mathias, 30 March 2023, 09:30-10:00 CEST
- “Air pollution and lung cancer” by Charles Swanton, 31 March 2023, 14:30-15.00 CEST
Media registration
ESMO welcomes media interested in obtaining information and reporting on cancer issues. Only through the official accreditation process, accredited media representatives will be able to access: scientific and educational sessions, poster area, exhibition and industry satellite symposia, congress webcasts, embargoed material. For ELCC the accreditation will also grant permission to the congress virtual platform and its features.
ESMO sarcoma and rare cancers congress media registration form
European Lung Cancer Congress media registration form
Further information
ESMO and ELCC Press Office
press@esmo.org
Notes to Editors
Please make sure to use the official name of the meetings in your reports: ESMO Sarcoma and Rare Cancers Congress 2023 or European Lung Cancer Congress 2023
and the official congress hashtags: #ESMOSarcomaandrarecancers23 and #ELCC23
Follow the conversation on Twitter, LinkedIn, Instagram, Facebook